|
ZNF697 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.090100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.574200E-02 |
| Normal-vs-Stage2 |
7.891400E-01 |
| Normal-vs-Stage3 |
2.043600E-01 |
| Normal-vs-Stage4 |
1.221810E-02 |
| Stage1-vs-Stage2 |
3.650000E-01 |
| Stage1-vs-Stage3 |
9.889600E-01 |
| Stage1-vs-Stage4 |
3.280800E-01 |
| Stage2-vs-Stage3 |
4.599000E-01 |
| Stage2-vs-Stage4 |
1.274750E-01 |
| Stage3-vs-Stage4 |
3.405600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.111020E-01 |
| Normal-vs-AfricanAmerican |
3.014400E-02 |
| Normal-vs-Asian |
1.178000E-01 |
| Caucasian-vs-AfricanAmerican |
2.814400E-01 |
| Caucasian-vs-Asian |
5.560800E-01 |
| AfricanAmerican-vs-Asian |
7.103600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.420200E-02 |
| Normal-vs-Female |
9.920800E-01 |
| Male-vs-Female |
1.607700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.205800E-02 |
| Normal-vs-Extreme_Weight |
1.010470E-02 |
| Normal-vs-Obese |
1.787230E-01 |
| Normal-vs-Extreme_Obese |
6.129600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.024400E-01 |
| Normal_Weight-vs-Obese |
5.424800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.077800E-01 |
| Extreme_Weight-vs-Obese |
1.433380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.630800E-01 |
| Obese-vs-Extreme_Obese |
7.628800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.244800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.055210E-01 |
| Normal-vs-Age(61-80Yrs) |
1.987910E-02 |
| Normal-vs-Age(81-100Yrs) |
9.106000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.774000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.985000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.973000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.605800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.436200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.956350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.505900E-02 |
| Normal-VS-Type2 PRCC |
2.655000E-01 |
| Normal-VS-KIRP CIMP |
9.379600E-01 |
| Normal-VS-Unclassified PRCC |
7.948600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.570400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.486800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.207000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.620200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.746800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.437600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.370000E-01 |
| Normal-vs-N1 |
1.424770E-01 |
| Normal-vs-N2 |
7.630000E-02 |
| N0-vs-N1 |
8.324000E-01 |
| N0-vs-N2 |
5.507600E-01 |
| N1-vs-N2 |
5.911800E-01 |
|
|
